Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Piperacillin-tazobactam”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Ended earlyNCT02176122
What this trial is testing

RCT Meropenem vs Piperacillin-Tazobactam for Definitive Treatment of BSI's Due to Ceftriaxone Non-susceptible Escherichia Coli and Klebsiella Spp.

Who this might be right for
Bloodstream Infections
The University of Queensland 391
Large-scale testing (Phase 3)Study completedNCT02493764
What this trial is testing

Imipenem/Relebactam/Cilastatin Versus Piperacillin/Tazobactam for Treatment of Participants With Bacterial Pneumonia (MK-7655A-014)

Who this might be right for
Bacterial Pneumonia
Merck Sharp & Dohme LLC 537
Large-scale testing (Phase 3)Study completedNCT03269994
What this trial is testing

Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy?

Who this might be right for
Pancreatic CancerPancreas CancerPancreatic Diseases
Memorial Sloan Kettering Cancer Center 967
Not applicableUnknownNCT01714557
What this trial is testing

Prophylactic Piperacillin/Tazobactam in Hematopoietic Stem Cell Transplantation

Who this might be right for
NeutropeniaHematopoietic Stem Cell Transplantation
Chinese PLA General Hospital 150
Post-approval studies (Phase 4)Study completedNCT04895657
What this trial is testing

Extended-infusion of Piperacillin-Tazobactam Versus Intermittent Infusion

Who this might be right for
Gram-Negative Infections
Ain Shams University 56
Not applicableNot Yet RecruitingNCT07818265
What this trial is testing

Differentiating True Nephrotoxicity From Pseudo-nephrotoxicity: A Prospective Comparative Study of Vancomycin Plus Piperacillin-Tazobactam vs. Meropenem Using Serum Creatinine and Cystatin-C

Who this might be right for
NephrotoxicityBacterial InfectionsAcute Kidney Injury+1 more
King Faisal Specialist Hospital & Research Center 304
Large-scale testing (Phase 3)Ended earlyNCT01853982
What this trial is testing

Study of Intravenous Ceftolozane/Tazobactam Compared to Piperacillin/Tazobactam in Ventilator-Associated Pneumonia

Who this might be right for
Ventilator-Associated Pneumonia (VAP)
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 4
Post-approval studies (Phase 4)Study completedNCT02437045
What this trial is testing

Trial of Meropenem Versus Piperacillin-Tazobactam on Mortality and Clinial Response

Who this might be right for
Bloodstream Infections
The University of Queensland 100
Large-scale testing (Phase 3)Study completedNCT01577368
What this trial is testing

Piperacillin-Tazobactam Continuous Versus Intermittent Infusion for Pseudomonas Aeruginosa

Who this might be right for
Pseudomonas Aeruginosa Infection
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 76
Large-scale testing (Phase 3)Study completedNCT02166476
What this trial is testing

Efficacy/Safety of Meropenem-Vaborbactam Compared to Piperacillin-Tazobactam in Adults With cUTI and AP

Who this might be right for
Urinary Tract Infection ComplicatedAcute Pyelonephritis
Melinta Therapeutics, Inc. 550
Not applicableLooking for participantsNCT06076200
What this trial is testing

Population Pharmacokinetic of Piperacillin/Tazobactam in Maternal and Neonatal Populations

Who this might be right for
Early-Onset Neonatal Sepsis
Shandong University 50
Large-scale testing (Phase 3)Study completedNCT00629135
What this trial is testing

Moxifloxacin Plus Metronidazole Versus Piperacillin/Tazobactam for the Treatment of Patients With Intra-abdominal Abscesses

Who this might be right for
Abscess, Intra-Abdominal
Hannover Medical School 180
Post-approval studies (Phase 4)Temporarily pausedNCT03891433
What this trial is testing

Piperacillin/Tazobactam Versus Carbapenems in Non-bacteremic UTI Due to -ESBL-producing Enterobacteriaceae

Who this might be right for
Urinary Tract InfectionsEnterobacteriaceae InfectionsInfection Due to ESBL Bacteria+5 more
Universidad del Norte 198
Not applicableLooking for participantsNCT04436991
What this trial is testing

Antibiotic Dosing in Geriatric Patients At the Emergency Department

Who this might be right for
Elderly InfectionFrailtyFrail Elderly Syndrome+1 more
University Hospital, Ghent 180
Large-scale testing (Phase 3)Study completedNCT01994993
What this trial is testing

Antibiotic Safety (SCAMP)

Who this might be right for
Complicated Intra Abdominal Infections
Michael Cohen-Wolkowiez 260
Not applicableStudy completedNCT04282785
What this trial is testing

Point-of-care Monitoring of Antibiotic Concentration in Blood With UV-VIS Absorption Spectroscopy

Who this might be right for
SepsisInfection, Bacterial
Uppsala University 36
Not applicableStudy completedNCT00167999
What this trial is testing

Study Evaluating Piperacillin-Tazobactam on Certain Bacteria in Hematology and Oncology Units

Who this might be right for
Gram-Positive Bacterial InfectionsEscherichia Coli InfectionsKlebsiella Infections
Wyeth is now a wholly owned subsidiary of Pfizer 200
Large-scale testing (Phase 3)Looking for participantsNCT02735707
What this trial is testing

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

Who this might be right for
Community-acquired Pneumonia, Influenza, COVID-19
UMC Utrecht 20,000
Post-approval studies (Phase 4)WithdrawnNCT05355350
What this trial is testing

PipEracillin/Tazobactam Versus mERoPENem for Treatment of AmpC Producing Blood Stream Infections

Who this might be right for
Beta Lactam Resistant Bacterial InfectionEnterobacteriaceae InfectionsBacteremia
Rambam Health Care Campus
Post-approval studies (Phase 4)Study completedNCT06690905
What this trial is testing

Evaluation of the Achievement of a Pharmacodynamic Target of Piperacillin-Tazobactam for the Population With Obesity

Who this might be right for
InfectionsObesity and Obesity-related Medical Conditions
CR-CSSS Champlain-Charles-Le Moyne 45
Next Page